|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Echo Therapeutics, Inc
| | | Phone: | (508) 553-8850 | Fax: | (508) 5538760 | Year Established: | 1989 | Employees: | 10 | Ticker: | ECTE | Exchange: | OTCQB | Main Contact: | Alan W. Schoenbart, CEO & CFO | | Company Description | Echo Therapeutics is developing its non-invasive (transdermal & without needles), wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the diabetes fitness, weight loss and personal lifestyle wearable-health space. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals. | |
|
|
|
|
|